Business Combination - Summary of Final Purchase Price Allocation to Fair Value of Assets and Liabilities Acquired (Parenthetical) (Details) - Merger Agreement - Kuur Therapeutics, Inc.	May 04, 2021 $ / shares shares
Business Acquisition [Line Items]
Business acquisition, common stock issued \| shares	14,228,066
Business acquisition, share price \| $ / shares	$ 3.71

Number of shares of equity interests issued or issuable to acquire entity.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration